Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Turning Point Therapeutics, Inc. (TPTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
27 Jul 2022
TOMBESI PAOLO
EVP & Chief Financial Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
28,700
-3%
1,183
$74.94
$88,654.02
SELL
9 Feb 2022
Partridge Andrew John
EVP & Chief Commercial Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
22,078
-0%
221
$36.30
$8,022.30
SELL
9 Feb 2022
Reich Siegfried
EVP & Chief Scientific Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
3,448
-10%
397
$36.30
$14,411.10
SELL
9 Feb 2022
North Annette
EVP & General Counsel, Officer
Turning Point Therapeutics, Inc.
(TPTX)
11,696
-5%
669
$36.30
$24,284.70
SELL
9 Feb 2022
Hirmand Mohammad
EVP & Chief Medical Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
6,838
-8%
669
$36.30
$24,284.70
SELL
9 Feb 2022
Countouriotis Athena
President & CEO, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
47,930
-5%
2,971
$36.30
$107,847.30
SELL
30 Aug 2021
North Annette
EVP, General Counsel & Secty., Officer
Turning Point Therapeutics, Inc.
(TPTX)
12,365
-44%
10,000
$80.00
$800,000.00
SELL
14 Jul 2021
Partridge Andrew John
EVP & Chief Commercial Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
21,767
-7%
1,869
$74.90
$139,988.11
BUY
21 Jun 2021
Alles Mark J
Director
Turning Point Therapeutics, Inc.
(TPTX)
2,000
+100%
2,000
$81.34
$162,680.00
SELL
15 Jun 2021
North Annette
EVP, General Counsel & Secty., Officer
Turning Point Therapeutics, Inc.
(TPTX)
21,699
-40%
15,000
$77.03
$1,155,433.00
SELL
22 Mar 2021
Baker Brian Lee
SVP of Finance and Admin., Officer
Turning Point Therapeutics, Inc.
(TPTX)
27,632
-50%
28,435
$100.65
$2,862,081.80
SELL
8 Mar 2021
North Annette
EVP, General Counsel & Secty., Officer
Turning Point Therapeutics, Inc.
(TPTX)
25,983
-43%
20,000
$109.80
$2,195,939.50
SELL
4 Mar 2021
Reich Siegfried
EVP & Chief Scientific Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
36,390
-49%
35,550
$105.04
$3,734,075.20
SELL
9 Feb 2021
Countouriotis Athena
President & CEO, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
54,818
-52%
60,000
$137.48
$8,249,038.50
SELL
1 Feb 2021
North Annette
EVP, General Counsel & Secty., Officer
Turning Point Therapeutics, Inc.
(TPTX)
8,616
-74%
25,000
$125.89
$3,147,362.80
SELL
1 Feb 2021
Larson Yi
EVP & Chief Financial Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
16,002
-65%
30,000
$126.73
$3,801,917.50
SELL
7 Jan 2021
Baker Brian Lee
SVP of Finance and Admin., Officer
Turning Point Therapeutics, Inc.
(TPTX)
29,446
-51%
31,238
$122.26
$3,819,090.20
SELL
4 Jan 2021
Hirmand Mohammad
EVP and Chief Medical Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
284
-97%
10,300
$120.43
$1,240,405.80
SELL
9 Jun 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
549,471
-1%
9,500
$65.81
$625,193.75
SELL
4 Jun 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
566,511
-8%
55,500
$64.16
$3,560,647.50
BUY
21 May 2020
George Simeon
Director
Turning Point Therapeutics, Inc.
(TPTX)
2,253,660
+3%
83,333
$60.00
$4,999,980.00
BUY
21 May 2020
GLAXOSMITHKLINE PLC
Director
Turning Point Therapeutics, Inc.
(TPTX)
2,253,660
+3%
83,333
$60.00
$4,999,980.00
BUY
21 May 2020
Countouriotis Athena
President & CEO, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
26,872
+18%
4,166
$60.00
$249,960.00
SELL
19 May 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
605,483
-3%
21,000
$59.18
$1,242,703.00
SELL
8 May 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
637,153
-1%
11,500
$53.86
$619,351.25
SELL
5 May 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
651,077
-7%
55,500
$53.27
$2,956,634.00
SELL
22 Apr 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
697,170
-2%
21,000
$51.57
$1,082,978.80
SELL
9 Apr 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
714,891
-1%
12,208
$47.60
$581,085.50
SELL
6 Apr 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
738,797
-6%
55,500
$44.87
$2,490,476.50
SELL
26 Mar 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
786,991
-1%
11,500
$46.03
$529,371.60
SELL
23 Mar 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
809,283
-3%
31,792
$43.11
$1,370,451.20
SELL
10 Mar 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
829,783
-5%
44,000
$40.84
$1,796,842.80
SELL
24 Feb 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
871,983
-2%
21,000
$52.16
$1,095,422.20
SELL
13 Feb 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
792,519
-1%
11,500
$61.84
$711,137.00
SELL
10 Feb 2020
Cui Jingrong Jean
Director
Turning Point Therapeutics, Inc.
(TPTX)
805,419
-6%
55,500
$64.03
$3,553,743.50
SELL
27 Jan 2020
Cui Jingrong Jean
Chief Scientific Officer, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
851,820
-2%
21,000
$58.25
$1,223,283.90
SELL
15 Jan 2020
Cui Jingrong Jean
Chief Scientific Officer, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
870,819
-1%
11,500
$53.12
$610,853.00
SELL
10 Jan 2020
Cui Jingrong Jean
Chief Scientific Officer, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
895,829
-5%
55,500
$54.70
$3,036,045.80
SELL
18 Dec 2019
Cui Jingrong Jean
Chief Scientific Officer, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
946,319
-4%
48,500
$60.92
$2,954,577.50
SELL
13 Dec 2019
Cui Jingrong Jean
Chief Scientific Officer, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
999,619
-3%
41,500
$58.95
$2,446,620.20
SELL
10 Dec 2019
Cui Jingrong Jean
Chief Scientific Officer, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
1,037,219
-3%
34,500
$53.88
$1,858,709.00
SELL
5 Dec 2019
Cui Jingrong Jean
Chief Scientific Officer, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
1,069,219
-9%
118,500
$51.77
$6,134,753.00
BUY
10 Sep 2019
George Simeon
Director
Turning Point Therapeutics, Inc.
(TPTX)
2,170,327
+8%
177,777
$45.00
$7,999,965.00
BUY
10 Sep 2019
GLAXOSMITHKLINE PLC
Director
Turning Point Therapeutics, Inc.
(TPTX)
2,170,327
+8%
177,777
$45.00
$7,999,965.00
BUY
10 Sep 2019
Larson Yi
EVP & Chief Financial Officer, Officer
Turning Point Therapeutics, Inc.
(TPTX)
2,222
+100%
2,222
$45.00
$99,990.00
BUY
10 Sep 2019
Countouriotis Athena
President & CEO, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
22,000
+83%
10,000
$45.00
$450,000.00
BUY
22 Apr 2019
George Simeon
Director
Turning Point Therapeutics, Inc.
(TPTX)
1,992,550
+19%
325,000
$18.00
$5,850,000.00
BUY
22 Apr 2019
GLAXOSMITHKLINE PLC
Director, 10% Owner
Turning Point Therapeutics, Inc.
(TPTX)
1,992,550
+19%
325,000
$18.00
$5,850,000.00
BUY
22 Apr 2019
Cormorant Asset Management, LP
10% Owner
Turning Point Therapeutics, Inc.
(TPTX)
3,099,099
+14%
400,000
$18.00
$7,200,000.00
BUY
22 Apr 2019
ORBIMED ADVISORS LLC
Director
Turning Point Therapeutics, Inc.
(TPTX)
2,027,550
+21%
360,000
$18.00
$6,480,000.00
BUY
22 Apr 2019
Lu Hongbo
Director
Turning Point Therapeutics, Inc.
(TPTX)
1,727,550
+3%
60,000
$18.00
$1,080,000.00
BUY
22 Apr 2019
GORDON CARL L
Director
Turning Point Therapeutics, Inc.
(TPTX)
2,027,550
+21%
360,000
$18.00
$6,480,000.00
BUY
22 Apr 2019
Baker Brian Lee
VP of Finance and Admin., Officer
Turning Point Therapeutics, Inc.
(TPTX)
2,800
+100%
2,800
$18.00
$50,400.00
BUY
22 Apr 2019
Countouriotis Athena
President & CEO, Director, Officer
Turning Point Therapeutics, Inc.
(TPTX)
12,000
+100%
12,000
$18.00
$216,000.00
Home